期刊文献+

小鼠β-防御素2与甲型流感病毒HA1融合基因真核载体的构建与表达 被引量:2

Construction and expression of mBD2/HA1 fusion gene ineukaryotic expression system
下载PDF
导出
摘要 目的:构建小鼠β-防御素2(mBD2)与甲型流感病毒A/PR/8/34(H1N1)血凝素(HA1)基因融合表达的真核载体,并检测其在HEK293细胞中的表达。方法:用PCR技术分别从质粒pcDNA3.1(+)/mBD2和pcDNA3.1(+)/HA1中扩增mBD2与HA1基因片段,再用重叠延伸PCR法(overlap-PCR)将HA1与mBD2通过一段多肽接头Gly4Ser融合为mBD2-HA1。将mBD2-HA1融合基因插入真核表达载体pcDNA3.1(+),经酶切、PCR和测序鉴定正确后,用脂质体转入HEK293细胞,通过免疫荧光检测其瞬时表达。结果:融合基因mBD2-HA1的真核表达载体pcDNA3.1(+)/mBD2-HA1构建成功,并在HEK293细胞中成功表达融和蛋白。结论:融合基因mBD2-HA1真核表达载体的成功构建,为研究防御素在流感病毒核酸疫苗中的佐剂作用奠定了基础。 Objective :To construct the eukaryotic expression vector for mouse β-defensin 2 (mBD2) and influenza A virus (A/PR/8/34) HA1 fusion gene and express it in HEK293 cells. Methods:mBD2 and HA1 gene were amplified from plasmids pcD- NA3.1 ( + )/mBD2 and pcDNA3. 1 ( + )/HA1 respectively, and a polypeptide linker Gly4Ser was used to splice mBD2 and HA1 gene by overlap-PCR for constructing the chain of mBD2-HA1 fusion gene. mBD2-HA1 fragment was inserted into eukaryotic expressing plasmid pcDNA3. 1 ( + ) to construct pcDNA3. 1 ( + )/mBD2-HA1. After identification of restriction enzymes digestion, PCR and sequencing analysis, pcDNA3.1 ( + )/mBD2-HA1 was transfected into HEK293 cells by PolyFect Transfection Reagent. The transient expression of mBD2-HA1 gene was detected through immunofluorescence assay. Results:mBD2-HA1 fusion gene was gotten by overlap- PCR. Expression vector pcDNA3.1 ( + ) of mBD2-HA1 fusion gene was constructed successfully. The fusion protein could be detected in HEK293 cells transfected with pcDNA3.1 ( + )/mBD2-HA1. Conclusion: The success in the construction of eukaryotic expressing plasmid for mBD2-HA1 fusion gene made a solid foundation for further exploring the function of defensin against influenza virus through DNA vaccine.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2008年第1期8-10,15,共4页 Chinese Journal of Immunology
基金 国家自然科学基金资助课题(No.30671964)
关键词 Β-防御素 流感病毒 融合基因 重叠延伸PCR 免疫荧光 β-defensin Influenza virus Fusion gene Overlap-PCR lmmunofluorescence assay
  • 相关文献

参考文献10

  • 1朱元军,李明远.防御素抗HIV作用[J].国际病毒学杂志,2006,13(1):2-5. 被引量:12
  • 2Lehrer R,Ganz T.Defensine of vertebrate animals[J].Curr Opin Immunol,2002;14:96-102.
  • 3Lehrer B.Innate and adaptive mucosal immunity in protection against HIV infection[J].Vaccine,2003;21(suppl 2):68-76.
  • 4Oppenheim J,Yang D.Alarmins:chemotactic activators of immune responses[J].Current Opinion in Immunology,2005;17:359-365.
  • 5邹丽容,方芳,陈则.编码流感病毒血凝素基因和CD40L的核酸疫苗抗小鼠流感研究[J].中国病毒学,2004,19(2):105-109. 被引量:3
  • 6张卫东,曹康,李明远,施桥发,王保宁,蒋忠华,李虹.甲型流感病毒血凝素基因HA和HA_1真核载体的构建及其表达研究[J].四川大学学报(医学版),2006,37(2):176-179. 被引量:1
  • 7Biragyn A,Tani K,Michael C et al.Genetic fusion of chemokines to a self tumor antigen induces protective T cell dependent antitumor immunity[J].Nature Biotechnology,1999;17:253-258.
  • 8Biragyn A,Coscia M,Adelchi Ruffini P et al.Chemokine receptormediated delivery directs self-tumor antigen efficiently into the class Ⅱ processing pathway in vitro and induces protective immunity in vivo[J].Blood,2004;104:1961-1969.
  • 9Yang D,Biragyn A,W Kwak L et al.Mammalian defensins in immunity:more than just microbicidal[J].Trends in Immunology,2002;23:291-296.
  • 10Leikina E,Delanoe-Ayari H,Lehrer R et al.Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins[J].Nature Immunology,2005;6:995-1002.

二级参考文献62

  • 1[23]Rankin J A, Reynolds H Y. Pulmonary host defenses: humoral immune components, In: Gallin JI, Fauci AS, editors. Advances in host defense mechanisms[M]. vol. 4, New York: Raven; 1985. p115-140.
  • 2[24]Mitchell J A, Green T D, Bright R A, et al. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins[J]. Vaccine, 2003,21(9-10): 902-914.
  • 3[25]Ross T M, Xu Y, Bright RA, et al. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge[J]. Nat Immunol, 2000, 1(2): 127-131.
  • 4[1]Min W, Lillehoj H S, Burnside J, et al. Adjuvant effects of IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma TGF-beta4 and lymphotactin on DNA vaccination against Eimeria acervulina[J]. Vaccine, 2001,20(1-2): 267-274.
  • 5[2]Ramsay J, Kohonen-Corish M. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo[J]. Eur J Immunol, 1993, 23: 3141-3145.
  • 6[3]O'Neill E, Martinez I, Villinger F, et al. Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration[J]. J Med Primatol, 2002,31(4-5): 217-227.
  • 7[4]Grossman M E, Brown M P, Brenner M K. Antimumor response induced by transgenic expression of CD40 ligand[J]. Hum Gene Ther, 1997, 8: 1935-1943.
  • 8[5]Kimm J J, Nottingham L K, Wilson D M, et al. Engineering DNA vaccine codelivery of co-stimulatory molecule genes[J]. Vaccine, 1998,16: 1828-1835.
  • 9[6]Armitage R J, Fanslow W C, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40[J]. Nature, 1992, 357: 80-82.
  • 10[7]Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand[J]. Annu Rev Immunol, 1994, 12: 881-922.

共引文献13

同被引文献12

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部